相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Eleven genomic loci affect plasma levels of chronic inflammation marker soluble urokinase-type plasminogen activator receptor
Joseph Dowsett et al.
COMMUNICATIONS BIOLOGY (2021)
Single-cell RNA counting at allele and isoform resolution using Smart-seq3
Michael Hagemann-Jensen et al.
NATURE BIOTECHNOLOGY (2020)
c-Src is in the effector pathway linking uPAR and podocyte injury
Jeffrey B. Kopp et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
uPAR isoform 2 forms a dimer and induces severe kidney disease in mice
Changli Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method
Wolfgang Winnicki et al.
SCIENTIFIC REPORTS (2019)
Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab
Nada Alachkar et al.
BMC NEPHROLOGY (2018)
Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease
Eunsil Hahm et al.
NATURE MEDICINE (2017)
Removal of focal segmental glomerulosclerosis (FSGS) factor suPAR using CytoSorb
Heiko Schenk et al.
JOURNAL OF CLINICAL APHERESIS (2017)
A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease
Salim S. Hayek et al.
NATURE MEDICINE (2017)
suPAR and chronic kidney disease-a podocyte story
Martin Zeier et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2017)
A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
Joann M. Spinale et al.
KIDNEY INTERNATIONAL (2015)
Soluble Urokinase Receptor and Chronic Kidney Disease
Salim S. Hayek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes
Massimo Alfano et al.
SCIENTIFIC REPORTS (2015)
Renal and Hematological Effects of CLCF-1, a B-Cell-Stimulating Cytokine of the IL-6 Family
Virginia J. Savin et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Administration of Recombinant Soluble Urokinase Receptor Per Se Is Not Sufficient to Induce Podocyte Alterations and Proteinuria in Mice
Dominique Cathelin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children
Aditi Sinha et al.
KIDNEY INTERNATIONAL (2014)
A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease
Takehiko Wada et al.
KIDNEY INTERNATIONAL (2014)
Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?
Detlef Schloendorff
KIDNEY INTERNATIONAL (2014)
The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis
Bjorn Meijers et al.
KIDNEY INTERNATIONAL (2014)
suPAR is the circulating factor in some but not all FSGS
Howard Trachtman et al.
NATURE REVIEWS NEPHROLOGY (2014)
Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis
Yutaka Harita et al.
PEDIATRIC NEPHROLOGY (2014)
A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation
Marianne Delville et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Transmission of Glomerular Permeability Factor Soluble Urokinase Plasminogen Activator Receptor (suPAR) From a Mother to Child
Markus J. Kemper et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Management of Severe Recurrent Focal Segmental Glomerulosclerosis Through Circulating Soluble Urokinase Receptor Modification
Christian Morath et al.
AMERICAN JOURNAL OF THERAPEUTICS (2013)
Serum Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Idiopathic FSGS in Children: A Single-Center Report
Margret E. Bock et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Serum suPAR in patients with FSGS: trash or treasure?
Rutger J. H. Maas et al.
PEDIATRIC NEPHROLOGY (2013)
Podocyte Effacement Closely Links to suPAR Levels at Time of Posttransplantation Focal Segmental Glomerulosclerosis Occurrence and Improves With Therapy
Nada Alachkar et al.
TRANSPLANTATION (2013)
A Flexible Multidomain Structure Drives the Function of the Urokinase-type Plasminogen Activator Receptor (uPAR)
Haydyn D. T. Mertens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Crystal Structure of the Urokinase Receptor in a Ligand-Free Form
Xiang Xu et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Circulating suPAR in Two Cohorts of Primary FSGS
Changli Wei et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
Changli Wei et al.
NATURE MEDICINE (2011)
Circulating Permeability Factors in Idiopathic Nephrotic Syndrome and Focal Segmental Glomerulosclerosis
Ellen T. McCarthy et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Regulation of cell signalling by uPAR
Harvey W. Smith et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
PLAUR polymorphisms and lung function in UK smokers
Ceri E. Stewart et al.
BMC MEDICAL GENETICS (2009)
suPAR: The molecular crystal ball
Maria Thuno et al.
DISEASE MARKERS (2009)
Antibodies to protein tyrosine phosphatase receptor type O (PTPro) increase glomerular albumin permeability (Palb)
Deane S. Charba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes
Qing Huai et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Modification of kidney barrier function by the urokinase receptor
Changli Wei et al.
NATURE MEDICINE (2008)
Mapping of the vitronectin-binding site on the urokinase receptor -: Involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region
Henrik Gardsvoll et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Structure of human urokinase plasminogen activator in complex with its receptor
Q Huai et al.
SCIENCE (2006)
Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide
P Llinas et al.
EMBO JOURNAL (2005)
Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules?
N Montuori et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Urokinase receptor modulates cellular and angiogenic responses in obstructive nephropathy
GQ Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy
GQ Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection
JJTH Roelofs et al.
KIDNEY INTERNATIONAL (2003)
uPAR: A versatile signalling orchestrator
F Blasi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization
N Sidenius et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo
N Sidenius et al.
FEBS LETTERS (2000)
分享论文
